临床试验

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

NCT：NCT06388707 · RECRUITING

NCT编号NCT06388707

状态RECRUITING

开始日期2024-09-13

完成时间2027-10-31

SponsorNaviFUS Corporation (INDUSTRY)

First posted2024-04-29

Last updated2026-09-15

简要摘要

This will be a prospective, open-label, single-arm, multi-center, pilot study to evaluate the safety, tolerability, and preliminary efficacy of low-intensity focused ultrasound (LIFU) neuromodulation using NaviFUS System in patients with drug-resistant unilateral or bilateral temporal lobe epilepsy (DR-TLE).

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。